 Home > Medical News > Medicines Company News > AffaMed Therapeutics Announces Appointment of Vijay Karwal as Chief Financial Officer

AffaMed Therapeutics Announces Appointment of Vijay Karwal as Chief Financial Officer

 Last Update: 2021-07-06
 Source: Internet
 Author: User

Tags

time financial

global chemical company

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

AffaMed Therapeutics, a clinical-stage innovative biomedical company dedicated to meeting the global needs for the treatment of ophthalmic, neurological and psychiatric diseases, announced the appointment of Mr.
Vijay Karwal as its chief financial officer
.
Mr.

Karwal will report to the company’s CEO, Dr.

Dr.
Dayao Zhao, CEO of AffaMed, said: “I am very pleased that Vijay has joined AffaMed
at a critical moment in the development of the company .
In the field of commercial and investment banking, Vijay has a global vision.

He has not only accumulated rich experience in financial transactions and corporate strategy consulting, but also It has also achieved remarkable success

Mr.

Karwal is based in Hong Kong

Mr.
Vijay Karwal said: “Since its establishment in 2019, AffaMed has successfully built a development platform that serves patients in Greater China and the world through innovative treatment methods and solutions
.
Under the leadership of Dr.

Dayao Zhao and the strong support of investors , The company has assembled excellent teams and talents in clinical development, regulatory affairs and business development

In March 2021, AffaMed successfully completed more than US$170 million in Series B financing and announced an agreement with SIFI SpA, a leading international ophthalmology company.

) Market development, production and sales of innovative high-quality intraocular lens (IOL) products

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.